Iovance Biotherapeutics, Inc.
Clinical trials sponsored by Iovance Biotherapeutics, Inc., explained in plain language.
-
Immune cell attack: new hope for tough melanoma?
Disease control OngoingThis study tests a personalized cell therapy called lifileucel (TIL) for people with advanced melanoma that has not responded to standard treatments. About 100 adults with stage III or IV melanoma will receive their own immune cells that have been specially grown in a lab to figh…
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 04:13 UTC
-
Immune cell attack: new hope for kids with returning cancers
Disease control OngoingThis early-stage study tests whether a personalized immune cell therapy called TIL is safe and can fight cancer in children, teenagers, and young adults (ages up to 21) with solid tumors that have come back or stopped responding to standard treatments. Participants receive their …
Phase: PHASE1 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 04, 2026 16:22 UTC